M21-416 BOTOX Ph3 Pivotal MMP
ClinicalTrials.gov NCT06387394
Research payments
$119,476
Through program year 2024, $119,476 in research payments was reported against M21-416 BOTOX Ph3 Pivotal MMP, across 20 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT06387394
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $119,476 | 20 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Heather Woolery Lloyd Miami, FL Named on 1 payment
- Lisa Grunebaum Scottsdale, AZ Named on 1 payment
- Derek Jones Los Angeles, CA Named on 1 payment
- Melanie Appell Birmingham, AL Named on 1 payment
- Deanne Mraz Westport, CT Named on 1 payment
- William Coleman Metairie, LA Named on 1 payment
- Susan Weinkle Bradenton, FL Named on 1 payment
- Michael Gold Nashville, TN Named on 1 payment
- Craig Teller Bellaire, TX Named on 1 payment
- Wendy McFalda Clarkston, MI Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.